BABA
Alibaba Group Holding Limited
BABA's outlook is improving, though it still trails on the overall score.
DAN
Dana Incorporated
DAN has the edge over BABA overall, supported by stronger modeled upside and stronger valuation.
BABA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Healthy |
BABA's balance sheet is currently healthy, and its revenue is stable, but its profitability and cash flow are under pressure.
DAN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Under pressure | |
| Stable |
DAN's profitability is currently healthy, and its revenue and balance sheet are stable, but its cash flow is under pressure.
BABA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $69.66 | -26% |
| Fair | 20x | $86.59 | -8.2% |
| Current | 21x | $94.36 | — |
| Expensive | 26x | $115 | +22% |
Historical ranges are pointers, not guarantees.
BABA's PE is 21x, but its earnings don't support one, so it isn't a reliable read right now.
DAN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 2.4x | $23.26 | — |
| Cheap | 5.9x | $56.02 | +141% |
| Forward | 6.6x | $23.26 | — |
| Fair | 16x | $152 | +553% |
| Expensive | 53x | $506 | +2075% |
Historical ranges are pointers, not guarantees.
DAN has the edge over BABA in the historical PE scenario, which offers more potential upside but is not a forecast.
BABA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
BABA has the edge over DAN on the outlook, with more favorable profitability expectations.
DAN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect strong earnings and revenue growth for DAN, with profitability holding steady. However, they disagree widely on these estimates.
BABA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $4.42 | -52% |
| Q1 2026 | $6.57 | -18% |
| Q4 2025 | $5.79 | -22% |
| Q3 2025 | $7.85 | +49% |
| Q2 2025 | $9.27 | +116% |
| Q1 2025 | $8.06 | +71% |
| Q4 2024 | $7.47 | +24% |
| Q3 2024 | $5.26 | -35% |
BABA's earnings per share have fallen from their peak: $4.42 over the past year, against $9.27 in mid-2025. Its recent earnings include one-off gains.
DAN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.54 | -63% |
| Q3 2026 | $9.55 | +2022% |
| Q2 2026 | $10.05 | +$10.21 |
| Q1 2026 | $10.29 | +$10.53 |
| Q4 2025 | $0.57 | +$0.96 |
| Q3 2025 | $0.45 | +$0.56 |
| Q2 2025 | -$0.16 | -$0.15 |
| Q1 2025 | -$0.24 | -367% |
| Q4 2024 | -$0.39 | -250% |
DAN has the edge over BABA on earnings, with more consistent year-over-year improvement.
BABA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $40.2B | +8.3% |
| Q1 2026 | $36.5B | +2.9% |
| Q4 2025 | $42.7B | +1.7% |
| Q3 2025 | $37.2B | +4.8% |
| Q2 2025 | $37.2B | +1.8% |
| Q1 2025 | $35.5B | +6.6% |
| Q4 2024 | $42B | +7.6% |
| Q3 2024 | $35.5B | +5.2% |
BABA has the edge over DAN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 7.2% | -6.9 points |
| Q1 2026 | -0.3% | -12 points |
| Q4 2025 | 7.1% | -7.6 points |
| Q3 2025 | 2.2% | -13 points |
| Q2 2025 | 14% | -0.7 points |
| Q1 2025 | 12% | +5.4 points |
| Q4 2024 | 15% | +6.1 points |
| Q3 2024 | 15% | 0 points |
BABA has the edge over DAN on profitability, with a higher operating margin.
DAN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2B | +6.3% |
| Q2 2026 | $2B | +3.9% |
| Q1 2026 | $1.9B | -21% |
| Q4 2025 | $1.9B | -20% |
| Q3 2025 | $1.9B | -23% |
| Q2 2025 | $1.9B | -29% |
| Q1 2025 | $2.4B | -14% |
| Q4 2024 | $2.3B | -6.4% |
DAN's revenue is recovering but still below its 2023 peak: $2B last quarter, up 6.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 4.5% | +1.8 points |
| Q2 2026 | 3.8% | +2.9 points |
| Q1 2026 | 1% | -2 points |
| Q4 2025 | 3.3% | +4.9 points |
| Q3 2025 | 2.8% | -0.8 points |
| Q2 2025 | 0.8% | -3 points |
| Q1 2025 | 3.1% | +0.5 points |
| Q4 2024 | -1.5% | -2 points |
DAN's operating margin was 4.5% last quarter, up 1.8 points from the same quarter a year ago.
BABA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$6.7B | -$4.1B |
| Q1 2026 | -$2.7B | +$1.5B |
| Q4 2025 | $1B | -90% |
| Q3 2025 | -$3.2B | -254% |
| Q2 2025 | -$2.7B | -182% |
| Q1 2025 | -$4.2B | -12231% |
| Q4 2024 | $10.4B | -4.8% |
| Q3 2024 | $2.1B | -62% |
BABA's free cash flow has turned negative after years in the green: −$11.6B over the past year.
DAN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $32M | -48% |
| Q2 2026 | -$33M | -1200% |
| Q1 2026 | -$257M | -$145M |
| Q4 2025 | $345M | +132% |
| Q3 2025 | $62M | +$73M |
| Q2 2025 | $3M | -97% |
| Q1 2025 | -$112M | +$60M |
| Q4 2024 | $149M | +9.6% |
DAN has the edge over BABA on cash generation, producing positive trailing cash flow while its opponent burns cash.
BABA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +11.1M shares |
| 1 year | +0.9% | +21.4M shares |
| 3 years | -6.2% | -161M shares |
| 5 years | -12% | -339M shares |
| Available history | -8.4% | -221M shares |
BABA has 2.4B diluted shares, up 0.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $269.8M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
BABA spent $270M buying back its own shares over the past year, after none the year before.
DAN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -3.7% | -4M shares |
| 1 year | -19% | -25.3M shares |
| 3 years | -27% | -39.2M shares |
| 5 years | -28% | -40.7M shares |
| Available history | -27% | -39.6M shares |
DAN has the edge over BABA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $200M |
| Q2 2026 | $44M |
| Q1 2026 | $125M |
| Q4 2025 | $211M |
| Q3 2025 | $182M |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
DAN spent $580M buying back its own shares over the past year.
BABA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | 0.1x | Very low |
| Q3 2024 | -0.2x | Net Cash |
BABA has the edge over DAN on leverage, with a lower net debt burden relative to earnings.
DAN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.1x | Moderate |
| Q2 2026 | 1.8x | Healthy |
| Q1 2026 | 1.5x | Healthy |
| Q4 2025 | 4.8x | High |
| Q3 2025 | 5.7x | High |
| Q2 2025 | 4.9x | High |
| Q1 2025 | 3.5x | Elevated |
| Q4 2024 | 3.3x | Elevated |
DAN's net debt is about 2.1 years of its operating earnings (EBITDA), down from 5.7 years a year ago.
BABA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 12.7 | Oversold |
BABA's weekly RSI is 38 (neutral) and its Stochastic is 13 (oversold).
DAN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.5 | Neutral |
| Stochastic | 7.3 | Oversold |
DAN's weekly RSI is 39 (neutral) and its Stochastic is 7 (oversold).
BABA PE vs Consumer Cyclical Sector
| Metric | BABA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 18x | 19% above |
| PE % | 60 | 47 | 13 pts above |
BABA is trading at 21x earnings, a 19% premium to the Consumer Cyclical sector's median of 18x, though its earnings don't support one.
DAN PE vs Consumer Cyclical Sector
| Metric | DAN | Sector median | Relative |
|---|---|---|---|
| PE | 2.4x | 18x | 86% below |
| PE % | 2 | 47 | 45 pts below |
DAN has the edge over BABA on valuation relative to its sector.
BABA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $104.7 | 9.9% below |
| 20 week MA | $111.1 | 15% below |
| 50 week MA | $128.0 | 26% below |
| 100 week MA | $127.7 | 26% below |
| 200 week MA | $106.4 | 11% below |
BABA is in a downtrend: it's below all five of its weekly moving averages, and 11% below its 200-week average.
DAN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $26.0 | 11% below |
| 20 week MA | $27.7 | 16% below |
| 50 week MA | $29.8 | 22% below |
| 100 week MA | $23.2 | 0.4% above |
| 200 week MA | $18.3 | 27% above |
DAN has the edge over BABA on trend strength, trading above more of its moving averages.
BABA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $215.5 | $222.0 | +3% |
| 2021 | $222.0 | $118.7 | -47% |
| 2022 | $118.7 | $85.7 | -28% |
| 2023 | $85.7 | $77.5 | -9.5% |
| 2024 | $77.5 | $85.1 | +9.7% |
| 2025 | $85.1 | $152.2 | +79% |
| 2026 YTD | $152.2 | $94.4 | -38% |
BABA has finished lower in three of the last six years. It's down 38% so far in 2026.
DAN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $18.4 | $19.6 | +6.7% |
| 2021 | $19.6 | $22.5 | +15% |
| 2022 | $22.5 | $14.9 | -34% |
| 2023 | $14.9 | $14.6 | -2.1% |
| 2024 | $14.6 | $11.7 | -20% |
| 2025 | $11.7 | $23.9 | +104% |
| 2026 YTD | $23.9 | $23.3 | -2.6% |
DAN has the edge over BABA on returns for 2026, with the stronger performance.